Is tricuspid valve replacement a catastrophic operation?

• DOI: 10.1016/j.ejcts.2009.04.063
• Publication Date: 2009-07-09T10:04:17Z
• Authors: Kiick Sung; Pyo Won Park; Kay-Hyun Park; Tae-Gook Jun; Young Tak Lee; Ji-Hyuk Yang; Wook Sung Kim; Joomin Hwang
• Keywords: Mediastinitis

Objective: Tricuspid valve replacement (TVR) has a high postoperative mortality, despite recent advances in perioperative care. We report the results of our experience TVR with an emphasis on early mortality and morbidity long-term follow-up. Methods: Between October 1994 August 2007, 80 consecutive TVRs were performed 78 patients. The mean age was 48 ± 14 (range: 20–70) years. underlying disease patients classified as rheumatic (n = 54), congenital 12), endocarditis 10) or degenerative 4). Previous cardiac surgery had been 40 (50%). Isolated 24 (30%). Results: Hospital occurred one patient (1.4%). Postoperative morbidities included intra-aortic balloon pump 5), bleeding re-operation 4), delayed sternal closure 3), acute renal failure subdural haematoma extracorporeal membrane oxygenation 1), mediastinitis 1) pacemaker insertion In 42 patients, ventilator support needed for more than 72 h. Based multivariate analysis, (p ≪ 0.001) cardiopulmonary time 0.004) identified risk factors. Follow-up completed all duration 56 37 0–158) months. During follow-up period, there seven deaths (8.8%), including five deaths. 5- 8-year survival rates 95 3% 79 9% event-free 76 6% 61 9%, respectively. only predictors late low output 0.024). Conclusions: can be operative achieved thorough optimal management current era.